Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Halogenated Oxaallylamine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112441934B discloses a mild copper-catalyzed method for halogenated oxaallylamine synthesis, offering reliable supply and cost reduction in API manufacturing.
Novel copper-catalyzed method for halogenated oxaallylamines. Reduces steps, improves yield for beta-blocker intermediates. Ideal for API manufacturing cost reduction.